⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ennov and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Ennov
↗Paris, France
Ennov is a software company providing a unified compliance platform specifically for the life sciences industry. Their suite of solutions covers the entire product lifecycle, including clinical trials, regulatory affairs, quality management, pharmacovigilance, and commercial operations.
The company's platform is designed to eliminate data silos by using a single architecture that integrates content, data, and workflows. Ennov serves over 450-500 customers globally, ranging from emerging biotechnology firms to large multinational pharmaceutical companies, and is recognized for its focus on regulatory compliance and operational efficiency.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Life Sciences Compliance Software
SIZE & FINANCIALS
Employees:201-500
Revenue:$40M-$50M
Founded:1999
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Windcrest Partners
0
CORPORATE STRUCTURE
Key Partnerships:fme Life Sciences (Data migration and platform deployment), NNIT (IDMP compliance collaboration)
COMPETITION
Position:Challenger
Competitors:MetricStream, Greenlight Guru, MasterControl
LEADERSHIP
Key Executives:
Olivier Paris - Founder & CEO
LINKS
Website:ennov.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ennov. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.